Putnam Announces Distribution Rates for Open-End Funds
Tweet
Share
E-mailBOSTON--(BUSINESS WIRE)-- The Trustees of The Putnam Funds have declared the following distributions.
|
RECORD/ |
PAYMENT |
|||||
|
FUND NAME AND DISTRIBUTIONS |
EX DATE |
DATE |
||||
|
Putnam Diversified Income Trust - Class B Shares (PSIBX) |
||||||
| $0.0260 per share investment income | 7/14/2016 | 7/20/2016 | ||||
|
Putnam Diversified Income Trust - Class C Shares (PDVCX) |
||||||
| $0.0260 per share investment income | 7/14/2016 | 7/20/2016 | ||||
|
Putnam Diversified Income Trust - Class M Shares (PDVMX) |
||||||
| $0.0290 per share investment income | 7/14/2016 | 7/20/2016 | ||||
|
Putnam Diversified Income Trust - Class R Shares (PDVRX) |
||||||
| $0.0290 per share investment income | 7/14/2016 | 7/20/2016 | ||||
|
Putnam Diversified Income Trust - Class Y Shares (PDVYX) |
||||||
| $0.0310 per share investment income | 7/14/2016 | 7/20/2016 | ||||
|
Putnam Diversified Income Trust - Class R6 Shares (PDVGX) |
||||||
| $0.0320 per share investment income | 7/14/2016 | 7/20/2016 | ||||
|
Putnam U.S. Government Income Trust - Class B Shares (PGSBX) |
||||||
| $0.0250 per share investment income | 7/14/2016 | 7/20/2016 | ||||
|
Putnam U.S. Government Income Trust - Class C Shares (PGVCX) |
||||||
| $0.0250 per share investment income | 7/14/2016 | 7/20/2016 | ||||
|
Putnam U.S. Government Income Trust - Class M Shares (PGSMX) |
||||||
| $0.0300 per share investment income | 7/14/2016 | 7/20/2016 | ||||
|
Putnam U.S. Government Income Trust - Class R Shares (PGVRX) |
||||||
| $0.0300 per share investment income | 7/14/2016 | 7/20/2016 | ||||
|
Putnam U.S. Government Income Trust - Class Y Shares (PUSYX) |
||||||
| $0.0360 per share investment income | 7/14/2016 | 7/20/2016 |
View source version on businesswire.com: http://www.businesswire.com/news/home/20160714006271/en/
PUTNAM SHAREHOLDERS CONTACT:
1-800-225-1581
Source: Putnam Funds
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kura Oncology Reports Durable Clinical Activity of Darlifarnib Plus Cabozantinib in Cabozantinib-Naïve Clear Cell Renal Cell Carcinoma Patients at KCRS 2026
- GT Resources Receives 10-Year, Class III Exploration Permit for the Canalask Copper - Nickel Project, Yukon
- Transactions in connection with share buyback programme
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Putnam InvestmentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
